Qiujun Qiu - Publications

Targeting Ibrutinib to Tumor-Infiltrating T Cells with a Sialic Acid Conjugate-Modified Phospholipid Complex for Improved Tumor Immunotherapy.

Journal: Molecular pharmaceutics

Published: November 16, 2022

Persistent immune response: Twice tumor exfoliation induced by sialic acid-modified vincristine sulfate liposomes.

Journal: International journal of pharmaceutics

Published: July 13, 2022

Discovery in polyethylene glycol immunogenicity: The characteristic of intergenerational inheritance of anti-polyethylene glycol IgG.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: July 21, 2021

Sialic acid conjugate-modified liposomal platform modulates immunosuppressive tumor microenvironment in multiple ways for improved immune checkpoint blockade therapy.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: April 03, 2021

Photodynamic/ photothermal therapy enhances neutrophil-mediated ibrutinib tumor delivery for potent tumor immunotherapy: More than one plus one?

Journal: Biomaterials

Published: June 22, 2020

Sialic acid-conjugate modified liposomes targeting neutrophils for improved tumour therapy.

Journal: Biomaterials science

Published: February 26, 2020

Dual-Ligand Modification of PEGylated Liposomes Used for Targeted Doxorubicin Delivery to Enhance Anticancer Efficacy.

Journal: AAPS PharmSciTech

Published: February 27, 2019

Neutrophil-Mediated Delivery of Dexamethasone Palmitate-Loaded Liposomes Decorated with a Sialic Acid Conjugate for Rheumatoid Arthritis Treatment.

Journal: Pharmaceutical research

Published: January 13, 2019

Targeted delivery of ibrutinib to tumor-associated macrophages by sialic acid-stearic acid conjugate modified nanocomplexes for cancer immunotherapy.

Journal: Acta biomaterialia

Published: December 05, 2018

Redox- and pH-Sensitive Glycan (Polysialic Acid) Derivatives and F127 Mixed Micelles for Tumor-Targeted Drug Delivery.

Journal: Molecular pharmaceutics

Published: November 06, 2018

Exhausting tumor associated macrophages with sialic acid-polyethyleneimine-cholesterol modified liposomal doxorubicin for enhancing sarcoma chemotherapy.

Journal: International journal of pharmaceutics

Published: September 11, 2018

Murine RAW264.7 cells as cellular drug delivery carriers for tumor therapy: a good idea?

Journal: Cancer chemotherapy and pharmacology

Published: August 01, 2018